Literature DB >> 10386638

Radiation therapy and patient age in the survival from early-stage breast cancer.

S A Joslyn1.   

Abstract

PURPOSE: To analyze the use of radiation therapy following local excision of invasive localized breast cancer and subsequent survival by 5-year age category.
METHODS: Data for 27, 399 women diagnosed with localized stage of breast cancer and treated with local excision surgery from 1983 through 1992 were collected and provided by the national Surveillance, Epidemiology, and End Results (SEER) program. Use of radiation therapy was analyzed by race, ethnic background, geographic location, and age at diagnosis. Survival for women treated with local excision plus radiation therapy was compared to that of women treated with local excision alone for each 5-year age category.
RESULTS: Subjects in older age groups were significantly less likely (p < 0.001) to receive radiation following local excision compared to younger age groups. Statistically significant survival advantages were conferred on women receiving radiation therapy in each 5-year age category from age 35 to 84 years (ranging from p = 0.02 to p < 0.0001).
CONCLUSION: While the use of radiation therapy following local excision of early-stage breast tumors drops significantly in older age groups, women aged 35-84 years receiving radiation therapy had significant reductions in mortality. These results did not appear to be influenced by the presence of mortal comorbid conditions. These results strongly suggest the need to consider carefully patient characteristics other than age in deciding the course of treatment for early-stage breast cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10386638     DOI: 10.1016/s0360-3016(99)00071-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  Hypofractionated radiotherapy for early breast cancer: Review of phase III studies.

Authors:  Agata Kacprowska; Jacek Jassem
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-01

2.  Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study.

Authors:  S P Krotneva; K E Reidel; A Verma; N Mayo; R Tamblyn; A N Meguerditchian
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

3.  Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Authors:  Terry S Field; Jaclyn L F Bosco; Marianne N Prout; Heather T Gold; Sarah Cutrona; Pamala A Pawloski; Marianne Ulcickas Yood; Virginia P Quinn; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Am Coll Surg       Date:  2011-10-19       Impact factor: 6.113

4.  The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS.

Authors:  Celia Patricia Kaplan; Leah S Karliner; E Shelley Hwang; Joan Bloom; Susan Stewart; Dana Nickleach; Jessica Quinn; Angela Thrasher; Anna Maria Nápoles
Journal:  Breast Cancer Res Treat       Date:  2011-04-28       Impact factor: 4.872

5.  Risk factors and specific cancer types of second primary malignancies in patients with breast cancer receiving adjuvant radiotherapy: a case-control cohort study based on the SEER database.

Authors:  Chuanxin Xia; Lei Qin; Yinzhi Wang; Ling Yao; Benchang Shia; Szu-Yuan Wu
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

6.  Prognostic validation and treatment decision making of the 8th edition of the American Joint Committee on Cancer pathological staging system for elderly women with early-stage breast cancer.

Authors:  San-Gang Wu; Jian Shi; Wen-Wen Zhang; Jun Wang; Chen-Lu Lian; Jian Lei; Li Hua; Juan Zhou; Zhen-Yu He
Journal:  Aging (Albany NY)       Date:  2020-07-25       Impact factor: 5.682

7.  The Association between Age, Comorbidities and Use of Radiotherapy in Women with Breast Cancer: Implications for Survival.

Authors:  Jimmy T Efird; Sharyn Hunter; Sally Chan; Sarah Jeong; Susan L Thomas; Charulata Jindal; Tithi Biswas
Journal:  Medicines (Basel)       Date:  2018-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.